Cargando…
Prediction of severe adverse events, modes of action and drug treatments for COVID-19’s complications
Following SARS-CoV-2 infection, some COVID-19 patients experience severe host driven adverse events. To treat these complications, their underlying etiology and drug treatments must be identified. Thus, a novel AI methodology MOATAI-VIR, which predicts disease-protein-pathway relationships and repur...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531388/ https://www.ncbi.nlm.nih.gov/pubmed/34675303 http://dx.doi.org/10.1038/s41598-021-00368-6 |